BIOCRYST PHARMACEUTICALS, INC. (BCRX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.55M; Additional Paid in CapitalUSD $1.69B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-528.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.54M; Additional Paid in CapitalUSD $1.67B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-368.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.13M; Additional Paid in CapitalUSD $1.38B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $38.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $2.10M; Additional Paid in CapitalUSD $1.36B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $1.14M.
BIOCRYST PHARMACEUTICALS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax USD | Additional Paid in Capital, Common Stock USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | Treasury Stock, Shares, Acquired shares |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $2.55M | $1.69B | $-528.00K | $-2.15B | $-454.29M | 3 month · $14.69M | 3 month · $0.00 6 month · $0.00 | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $2.54M | $1.67B | $-368.00K | $-2.23B | $-553.84M | 3 month · $16.03M | 3 month · $0.00 | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $2.13M | $1.38B | $38.00K | $-1.51B | $-119.15M | 12 month · $85.14M | 12 month · $0.00 | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $2.10M | $1.36B | $1.14M | $-1.75B | $-387.89M | 3 month · $18.64M | 9 month · $0.00 | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $2.10M | $1.34B | $1.65M | $-1.76B | $-421.59M | 3 month · $21.30M | 3 month · $0.00 6 month · $0.00 | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $2.09M | $1.31B | $1.13M | $-1.77B | $-451.93M | 3 month · $21.37M | 3 month · $0.00 | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $2.08M | $1.29B | $921.00K | $-1.77B | $-475.93M | 12 month · $65.41M | 12 month · $0.00 | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $2.07M | $1.27B | $2.29M | $-1.74B | $-468.56M | 3 month · $17.25M | 9 month · $0.00 | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $2.07M | $1.25B | $557.00K | $-1.73B | $-475.61M | 3 month · $13.17M | 6 month · $0.00 | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $2.06M | $1.24B | $771.00K | $-1.72B | $-476.17M | 3 month · $13.65M | 3 month · $0.00 | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $2.06M | $1.22B | $1.34M | $-1.68B | $-455.53M | 12 month · $55.62M | 12 month · $0.00 | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $1.90M | $1.21B | $800.00K | $-1.62B | $-410.99M | 3 month · $12.28M | 3 month · $0.00 9 month · $0.00 | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $1.90M | $1.19B | $690.00K | $-1.58B | $-388.71M | 3 month · $12.84M | 6 month · $0.00 | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $1.89M | $1.18B | $585.00K | $-1.51B | $-328.29M | 3 month · $14.01M | 3 month · $0.00 | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $1.88M | $1.16B | $26.00K | $-1.45B | $-294.60M | 12 month · $44.70M | 12 month · $0.00 | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $1.86M | $1.14B | $-98.00K | $-1.38B | $-242.66M | 3 month · $9.95M | 3 month · $0.00 9 month · $0.00 | (m) | (m) | (m) |
| 2022-06-30 | $0.00 | $1.86M | $1.13B | $15.00K | $-1.34B | $-213.23M | 3 month · $9.87M | 6 month · $0.00 | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $1.86M | $1.12B | $186.00K | $-1.28B | $-164.22M | 3 month · $9.60M | 3 month · $0.00 | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $1.84M | $1.10B | $177.00K | $-1.21B | $-106.99M | 12 month · $34.64M | 12 month · $1.00K | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $1.80M | $1.04B | $114.00K | $-1.19B | $-147.04M | 3 month · $13.03M | 9 month · $-1.00K | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $1.79M | $1.02B | $87.00K | $-1.13B | $-106.08M | 3 month · $7.63M | 6 month · $1.00K | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $1.78M | $1.01B | $182.00K | $-1.09B | $-74.99M | 3 month · $5.48M | 3 month · $-1.00K | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $1.77M | $1.00B | $3.00K | $-1.02B | $-19.26M | 12 month · $14.79M | 12 month · $1.00K | (m) | 12 month · $14.82M | (m) |
| 2020-09-30 | $0.00 | $1.77M | $994.81M | $9.00K | $-962.95M | $33.64M | 3 month · $2.87M | 9 month · $1.00K | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $1.76M | $991.57M | $3.00K | $-916.83M | $76.51M | 3 month · $3.28M | 6 month · $1.00K | (m) | 3 month · $14.82M | (m) |
| 2020-03-31 | (m) | $1.54M | $880.32M | $14.00K | $-878.23M | $3.65M | 3 month · $2.75M | 3 month · $0.00 | (m) | (m) | (m) |
| 2019-12-31 | $0.00 | $1.54M | $877.30M | $39.00K | $-840.63M | $38.25M | 12 month · $17.72M | 12 month · $0.00 | (m) | 12 month · $19.88M | (m) |
| 2019-09-30 | (m) | $1.10M | $795.59M | $60.00K | $-838.01M | $-41.25M | 3 month · $5.33M | 9 month · $0.00 | (m) | (m) | (m) |
| 2019-06-30 | (m) | $1.10M | $790.08M | $41.00K | $-800.41M | $-9.19M | 3 month · $5.38M | 6 month · $0.00 | (m) | (m) | (m) |
| 2019-03-31 | (m) | $1.10M | $784.28M | $-89.00K | $-762.78M | $22.51M | 3 month · $3.32M | 3 month · $0.00 | (m) | (m) | (m) |
| 2018-12-31 | (m) | $1.10M | $780.40M | $-297.00K | $-731.97M | $49.23M | 12 month · $9.40M | 12 month · $2.00K | (m) | (m) | (m) |
| 2018-09-30 | (m) | $1.10M | $776.72M | $-410.00K | $-704.54M | $72.87M | 3 month · $2.08M | 9 month · $1.00K | (m) | (m) | (m) |
| 2018-06-30 | (m) | $989.00K | $720.59M | $-452.00K | $-674.94M | $46.18M | 3 month · $2.08M | 6 month · $0.00 | (m) | (m) | (m) |
| 2018-03-31 | (m) | $987.00K | $718.04M | $-476.00K | $-656.49M | $62.05M | 3 month · $2.90M | 3 month · $0.00 | (m) | (m) | (m) |
| 2018-01-01 | (m) | (m) | (m) | (m) | $-630.72M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $984.00K | $714.87M | $-243.00K | $-631.84M | $83.77M | 12 month · $12.62M | 12 month · $1.00K | (m) | (m) | (m) |
| 2017-09-30 | $0.00 | $984.00K | $711.97M | $-17.00K | $-612.30M | $100.63M | (m) | 9 month · $0.00 | (m) | (m) | (m) |
| 2017-06-30 | (m) | $804.00K | $620.45M | $-15.00K | $-597.17M | $24.08M | (m) | 6 month · $1.00K | (m) | (m) | (m) |
| 2017-03-31 | (m) | $804.00K | $618.01M | $-3.00K | $-580.28M | $38.53M | (m) | 3 month · $0.00 | (m) | (m) | (m) |
| 2016-12-31 | $0.00 | $738.00K | $566.91M | $-12.00K | $-566.06M | $1.58M | 12 month · $8.49M | 12 month · $11.00K | (m) | (m) | (m) |
| 2016-09-30 | (m) | $738.00K | $564.79M | $22.00K | $-561.56M | $3.99M | (m) | 9 month · $11.00K | (m) | (m) | (m) |
| 2016-06-30 | (m) | $737.00K | $562.63M | $46.00K | $-550.03M | $13.39M | (m) | 6 month · $10.00K | (m) | (m) | (m) |
| 2016-03-31 | (m) | $737.00K | $560.76M | $48.00K | $-533.75M | $27.80M | (m) | 3 month · $0.00 | (m) | (m) | (m) |
| 2015-12-31 | $0.00 | $734.00K | $558.11M | $-206.00K | $-510.92M | $47.72M | 12 month · $9.71M | 12 month · $13.00K | (m) | (m) | (m) |
| 2015-09-30 | $0.00 | $733.00K | $556.10M | $-1.00K | $-492.78M | $64.05M | (m) | 9 month · $13.00K | (m) | (m) | (m) |
| 2015-06-30 | $0.00 | $732.00K | $553.61M | $-92.00K | $-478.16M | $76.09M | (m) | 6 month · $12.00K | (m) | (m) | (m) |
| 2015-03-31 | $0.00 | $725.00K | (m) | $10.00K | $-483.06M | $64.37M | (m) | 3 month · $8.00K | $546.70M | (m) | (m) |
| 2014-12-31 | $0.00 | $720.00K | $542.94M | $-130.00K | $-467.90M | $75.64M | 12 month · $10.18M | 12 month · $0.00 | $542.94M | (m) | (m) |
| 2014-09-30 | $0.00 | $719.00K | (m) | $2.00K | $-456.23M | $83.45M | (m) | 9 month · $0.00 | $538.96M | (m) | (m) |
| 2014-06-30 | $0.00 | $717.00K | (m) | $3.00K | $-447.50M | $90.09M | (m) | 6 month · $0.00 | $536.86M | (m) | (m) |
| 2014-03-31 | (m) | $601.00K | (m) | $2.00K | $-432.85M | $-5.72M | (m) | 3 month · $0.00 | $426.52M | (m) | (m) |
| 2013-12-31 | $0.00 | $591.00K | (m) | $4.00K | $-422.71M | $-1.13M | 12 month · $4.37M | (m) | $420.99M | (m) | (m) |
| 2013-09-30 | (m) | $591.00K | (m) | $2.00K | $-417.28M | $3.41M | (m) | 3 month · $0.00 9 month · $0.00 | $420.10M | (m) | (m) |
| 2013-06-30 | (m) | $542.00K | (m) | $6.00K | $-409.28M | $-9.05M | (m) | 6 month · $0.00 | $399.68M | (m) | (m) |
| 2013-03-31 | (m) | $514.00K | (m) | $15.00K | $-397.11M | $-2.84M | (m) | 3 month · $0.00 | $393.74M | (m) | (m) |
| 2012-12-31 | (m) | $509.00K | (m) | $27.00K | $-392.60M | $-454.00K | 12 month · $4.17M | (m) | $391.61M | (m) | (m) |
| 2012-09-30 | (m) | $509.00K | (m) | $40.00K | $-381.55M | $9.78M | (m) | 3 month · $0.00 9 month · $0.00 | $390.78M | (m) | (m) |
| 2012-06-30 | (m) | $501.00K | (m) | $40.00K | $-371.85M | $15.66M | (m) | 6 month · $0.00 | $386.97M | (m) | (m) |
| 2012-03-31 | (m) | $492.00K | (m) | $49.00K | $-359.57M | $23.15M | (m) | (m) | $382.18M | (m) | (m) |
| 2011-12-31 | (m) | $457.00K | (m) | $40.00K | $-353.52M | $14.81M | 12 month · $4.77M | (m) | $367.83M | (m) | 12 month · 12.00K |
| 2011-09-30 | (m) | $452.00K | (m) | $50.00K | $-340.33M | $26.04M | (m) | (m) | $365.87M | (m) | (m) |
| 2011-07-13 | (m) | $70.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $0.00 | $70.00M | (m) | $92.00K | $-325.87M | $39.27M | (m) | (m) | $364.59M | (m) | (m) |
| 2010-12-31 | $0.00 | $450.00K | (m) | $105.00K | $-296.57M | $65.50M | 12 month · $6.30M | (m) | $361.52M | (m) | 12 month · 1.00K |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | $86.27M | 12 month · $5.53M | (m) | (m) | (m) | 12 month · 24.00K |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | $46.43M | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Greenland Mines Ltd (GRML) | United States | $2.362B | |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |